
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+30
WuXi Advanced Therapies - Accelerating Progress and Time to Market WuXi Advanced Therapies is a cell and gene therapy Contract Testing, Development and Manufacturing Organization (CTDMO) that is reducing the complexities of manufacturing by providing integrated platforms that enable cell and gene therapies to be developed, manufactured, and released faster and with greater predictability. Our Story By leveraging platforms and integrated testing our team provides expedited development and commercialization of cell, gene, protein and viral-based therapies. This approach enables new biopharmaceuticals to be developed, manufactured and released faster and with greater predictability, thereby reducing the complexities of high-touch, multi-vendor production...
Cell therapy,gene therapy,process development,cell banking,virology,autologous ,allogeneic,therapeutics,car-t,cdmo,cmo,contract manufacturing,therapeutics,biomanufacturing,bioprocessing,antibody drug conjugate,viral vector,biotechnology,protein therapeutic,viral clearance,biologics,biotherapeutics,immunotherapy,laboratory testing,preclinical safety,cell line characterization,adventitious agent testing,product packaging,lot release,analytical development,vaccine manufacturing,extractables & leachables,aav,lenti,and car-t
Wuxi advanced therapies operates in the Biotechnology research industry.
Wuxi advanced therapies's revenue is 11m - 100m
Wuxi advanced therapies has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.